Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romelia Barba

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Clinical Medicine|March 27, 2025
Performance of the Mayo Risk Score in Predicting Transplant and Mortality in a Single-Center U.S. Cohort of Primary Sclerosing CholangitisTamara Kahan, Ana Marenco-Flores, Natalia Rojas Amaris, et al.
Journal of Clinical Medicine|August 10, 2024
The External Validation of GLOBE and UK-PBC Risk Scores for Predicting Ursodeoxycholic Acid Treatment Response in a Large U.S. Cohort of Primary Biliary Cholangitis PatientsAna Marenco-Flores, Natalia Rojas Amaris, Tamara Kahan, et al.
Annals of Hepatology|December 27, 2023
Influence of socioeconomic factors on liver transplant survival outcomes in patients with autoimmune liver disease in the United StatesLeandro Sierra, Ana Marenco-Flores, Romelia Barba, et al.
European Journal of Gastroenterology & Hepatology|February 20, 2025
Metabolic dysfunction-associated steatotic liver disease correlates with higher lower graft survival in liver transplant recipients with hepatocellular carcinomaMarwan Alsaqa, Leandro Sierra, Ana Marenco-Flores, et al.
Journal of Clinical Medicine|October 28, 2023
Two Decades of Liver Transplants for Primary Biliary Cholangitis: A Comparative Study of Living Donors vs. Deceased Donor Liver TransplantationsEsli Medina-Morales, Mohamed Ismail, Romelia Barba Bernal, et al.
Annals of Hepatology|August 16, 2025
Primary biliary cholangitis has the worst quality of life indicators among the autoimmune liver diseases: A United States cohortLeandro Sierra, Bryan Ferrigno, Ana Marenco-Flores, et al.
Annals of Hepatology|May 31, 2026
Longitudinal health-related quality of life and associated factors in autoimmune liver diseasesDami Ko, Vilas Patwardhan, Natalia Rojas-Amaris, et al.
Gut|September 6, 2024
Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021Pojsakorn Danpanichkul, Kanokphong Suparan, Primrose Tothanarungroj, et al.
Journal of Clinical Medicine|November 27, 2025
Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease on Fatigue and Pruritus in Primary Sclerosing Cholangitis: A U.S. Single-Center StudyNatalia Rojas-Amaris, Ana Marenco-Flores, Carmen Lara-Romero, et al.
Alcohol, Clinical & Experimental Research|December 19, 2024
Increased mortality from alcohol use disorder, alcohol-associated liver disease, and liver cancer from alcohol among older adults in the United States: 2000 to 2021Pojsakorn Danpanichkul, Kwanjit Duangsonk, Ethan Kai Jun Tham, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Clinical Medicine|March 27, 2025
Performance of the Mayo Risk Score in Predicting Transplant and Mortality in a Single-Center U.S. Cohort of Primary Sclerosing CholangitisTamara Kahan, Ana Marenco-Flores, Natalia Rojas Amaris, et al.
Journal of Clinical Medicine|August 10, 2024
The External Validation of GLOBE and UK-PBC Risk Scores for Predicting Ursodeoxycholic Acid Treatment Response in a Large U.S. Cohort of Primary Biliary Cholangitis PatientsAna Marenco-Flores, Natalia Rojas Amaris, Tamara Kahan, et al.
Annals of Hepatology|December 27, 2023
Influence of socioeconomic factors on liver transplant survival outcomes in patients with autoimmune liver disease in the United StatesLeandro Sierra, Ana Marenco-Flores, Romelia Barba, et al.
European Journal of Gastroenterology & Hepatology|February 20, 2025
Metabolic dysfunction-associated steatotic liver disease correlates with higher lower graft survival in liver transplant recipients with hepatocellular carcinomaMarwan Alsaqa, Leandro Sierra, Ana Marenco-Flores, et al.
Journal of Clinical Medicine|October 28, 2023
Two Decades of Liver Transplants for Primary Biliary Cholangitis: A Comparative Study of Living Donors vs. Deceased Donor Liver TransplantationsEsli Medina-Morales, Mohamed Ismail, Romelia Barba Bernal, et al.
Annals of Hepatology|August 16, 2025
Primary biliary cholangitis has the worst quality of life indicators among the autoimmune liver diseases: A United States cohortLeandro Sierra, Bryan Ferrigno, Ana Marenco-Flores, et al.
Annals of Hepatology|May 31, 2026
Longitudinal health-related quality of life and associated factors in autoimmune liver diseasesDami Ko, Vilas Patwardhan, Natalia Rojas-Amaris, et al.
Gut|September 6, 2024
Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021Pojsakorn Danpanichkul, Kanokphong Suparan, Primrose Tothanarungroj, et al.
Journal of Clinical Medicine|November 27, 2025
Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease on Fatigue and Pruritus in Primary Sclerosing Cholangitis: A U.S. Single-Center StudyNatalia Rojas-Amaris, Ana Marenco-Flores, Carmen Lara-Romero, et al.
Alcohol, Clinical & Experimental Research|December 19, 2024
Increased mortality from alcohol use disorder, alcohol-associated liver disease, and liver cancer from alcohol among older adults in the United States: 2000 to 2021Pojsakorn Danpanichkul, Kwanjit Duangsonk, Ethan Kai Jun Tham, et al.
Pageof 2